News
Presidio Medical has received an IDE approval from the FDA, enabling a pivotal study of its neuromodulation platform.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback